Verrucous systemic lupus erythematosus

Acta Dermatovenerologica Croatica

Volumn 17, Issue 4, 2009, Pages 301-304

  Miteva, Ljubka ^a   Broshtilova, Valentina ^a   Schwartz, Robert A ^b  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Hypertrophic; Squamous cell carcinoma; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; METHYLPREDNISOLONE; RO ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; SKIN BIOPSY; SKIN DEFECT; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; VERRUCOUS SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; WARTS;

EID: 75149169267     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Sontherheimer RD. The lexicon of cutaneous lupus erythematosus - a review and personal perspective on the nomenclature and classifi-cation of the cutaneous manifestations of lupus erythematosus. Lupus 1997;6:122-31.
2. Callen JP. Discoid lupus erythematosus - variants and clinical associations. Clin Dermatol 1985;3:49-57.
3. Santa Cruz DJ, Uitto J, Eisen AZ, Prioleau PG. Verrucous lupus erythematosus: ultrastructural studies on a distinct variant of discoid lupus erythematosus. J Am Acad Dermatol 1983;9:82-90.
4. Uitto J, Santa Cruz DJ, Eisen AZ, Leone P. Verrucous lesions in patients with discoid lupus erythematosus. Br J Dermatol 1978;98:507-20.
5. Kuhn A, Schuppe HC, Ruzicka T, Lehmann P. Rare cutaneous manifestations of lupus erythematosus. A clinical overview. Hautarzt 2000;51:818-25.
6. rd edn. Heidelberg: Springer; 2009. pp. 716-41.
7. Rubenstein DJ, Huntley AC. Keratotic lupus erythematosus: treatment with isotretinoin. J Am Acad Dermatol 1986;14: 910-4.
8. Bechet PE. Lupus erythematosus hypertrophicus et profundus. Arch Dermatol Syphilol 1942;45:33-9.
9. Mulwafu WK, Fagan JJ, Jessop S. Squamous cell carcinoma in black patients with discoid lupus erythematosus. S Afr J Surg 2006;44:144-6.
10. Zedek DC, Smith ET Jr, Hitchcock MG, Feldman SR, Shelton BJ, White WL. Cutaneous lupus erythematosus simulating squamous neoplasia: the clinicopathologic conundrum and histopathologic pitfalls. J Am Acad Dermatol 2007;56:1013-20.
11. Ee HL, Ng PP, Tan SH, Goh CL. Squamous cell carcinoma developing in two Chinese patients with chronic discoid lupus erythematosus: the need for continued surveillance. Clin Exp Dermatol 2006;31:542-4.
12. Zawirska A, Adamski Z, Stawicka E, Schwartz RA. Lupus vulgaris exfoliativus: persistent for 40 years with an associated squamous cell carcinoma. Int J Dermatol 2009;48:125-7.
13. Perniciaro C, Randle HW, Perry HO. Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg 1995;21:255-7.
14. Cardinali C, Giomi B, Caproni M. Cutaneous hypertrophic lupus erythematosus in a patient with systemic involvement. Skin Med 2004;1:49-51.
15. Pock L, Petrovska P, Becvar R. Verrucous form of chilblain lupus erythematosus. J Eur Acad Dermatol Venereol 2001;15:1009-10.
16. Spann CR, Callen JP, Klein JB, Kulick KB. Clinical, serological and immunogenetic studies in patients with chronic discoid lupus erythematosus who have verrucous and/or hypertrophic skin lesions. J Rheumatol 1988;15:256-61.
17. Grupper CH, Berretti B. Lupus erythematosus and etretinate. In: Cunliffe WJ, Miller AJ, eds. Retinoid therapy: a review of clinical and laboratory research. New York, NY: Springer-Verlag; 1984. pp. 73-81.
18. Green S, Piette W. Treatment of hypertrophic lupus erythematosus with isotretinoin. J Am Acad Dermatol 1987;17:364-8.
19. Georgala S, Katoulis AC, Hasapi V, Koumantaki-Mathioudaki E. Thalidomide treatment for hypertrophic lupus erythematosus. Clin Exp Dermatol 1998;23:141.